Renee Marie Bogdanovic

Renee Marie Bogdanovic

Director/Board Member at Kent Pharmaceuticals Ltd.

35 year
Finance
Consumer Services
Health Technology

Profile

Renée joined Duke Street in 2017 from Charles River Associates in Munich, where she was a strategic and operational management consultant for the healthcare industry as well as Private Equity clients.
At Duke Street, her regional focus spans across western Europe, with particular concentration on DACH markets, and her sector expertise and origination focus is in healthcare.
She has worked on the firm’s investments in A-ROSA and Kent Pharmaceuticals and sits on the boards of Medi-Globe, A-ROSA and Kent.
Renée holds a BA (Hons) in Biology from New York University and an MSc in Neuroscience from Ludwig-Maximilians University in Munich.

Renee Marie Bogdanovic active positions

CompaniesPositionStart
Private Equity Investor 2016-12-31
Director/Board Member 2019-09-15
Director/Board Member 2019-08-31
All active positions of Renee Marie Bogdanovic

Former positions of Renee Marie Bogdanovic

CompaniesPositionEnd
Director/Board Member 2022-09-30
See the detail of Renee Marie Bogdanovic's experience

Training of Renee Marie Bogdanovic

New York University Undergraduate Degree
Ludwig-Maximilians-Universität München Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Renee Marie Bogdanovic's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies4

Finance

Health Technology

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Renee Marie Bogdanovic